Technical Analysis for SNSE - Sensei Biotherapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| 50 DMA Resistance | Bearish | 3.77% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 3.77% | |
| Inside Day | Range Contraction | 3.77% | |
| Wide Bands | Range Expansion | 3.77% | |
| 20 DMA Resistance | Bearish | -0.80% | |
| 50 DMA Resistance | Bearish | -0.80% | |
| Pocket Pivot | Bullish Swing Setup | -0.80% |
| Alert | Time |
|---|---|
| Up 5% | about 22 hours ago |
| Up 3% | about 22 hours ago |
| Up 2% | about 22 hours ago |
| Up 1% | about 22 hours ago |
| Possible Inside Day | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, engages in the discovery and development of therapies with an initial focus on treatments for cancer. The company develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response. It is engineering ImmunoPhage product candidates to directly target antigen presenting cells and modulate the tumor microenvironment through the targeted use of nanobodies which further enhances therapeutic activity. Sensei Biotherapeutics, Inc. was formerly known as Panacea Pharmaceuticals, Inc. The company was founded in 1999 and is headquartered in Rockville, Maryland.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunotherapy Tumor Cancer Immunotherapy Virotherapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunotherapy Tumor Cancer Immunotherapy Virotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.94 |
| 52 Week Low | 0.384 |
| Average Volume | 464,081 |
| 200-Day Moving Average | 0.78 |
| 50-Day Moving Average | 0.52 |
| 20-Day Moving Average | 0.53 |
| 10-Day Moving Average | 0.51 |
| Average True Range | 0.07 |
| RSI (14) | 47.37 |
| ADX | 21.08 |
| +DI | 18.74 |
| -DI | 13.24 |
| Chandelier Exit (Long, 3 ATRs) | 0.49 |
| Chandelier Exit (Short, 3 ATRs) | 0.65 |
| Upper Bollinger Bands | 0.61 |
| Lower Bollinger Band | 0.44 |
| Percent B (%b) | 0.33 |
| BandWidth | 31.90 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0054 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.60 | ||||
| Resistance 3 (R3) | 0.61 | 0.57 | 0.59 | ||
| Resistance 2 (R2) | 0.57 | 0.54 | 0.57 | 0.58 | |
| Resistance 1 (R1) | 0.53 | 0.53 | 0.55 | 0.53 | 0.58 |
| Pivot Point | 0.50 | 0.50 | 0.51 | 0.50 | 0.50 |
| Support 1 (S1) | 0.46 | 0.47 | 0.48 | 0.46 | 0.42 |
| Support 2 (S2) | 0.43 | 0.45 | 0.43 | 0.41 | |
| Support 3 (S3) | 0.39 | 0.43 | 0.41 | ||
| Support 4 (S4) | 0.39 |
